170 results on '"Alfaro, Raul"'
Search Results
2. Recycling of memory B cells between germinal center and lymph node subcapsular sinus supports affinity maturation to antigenic drift
3. Enhanced BCR signaling inflicts early plasmablast and germinal center B cell death
4. Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine
5. Elevated levels of enteric IgA in an unimmunised mouse model of Hyper IgM syndrome derived from gut-associated secondary lymph organs even in the absence of germinal centres
6. Taste and smell function in Wolfram syndrome
7. Elevated levels of enteric IgA in an unimmunised mouse model of Hyper IgM syndrome derived from gut-associated secondary lymph organs even in the absence of germinal centres
8. Enhancement of taste by retronasal odors in patients with Wolfram syndrome and decreased olfactory function
9. Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects
10. Effects of SLC22A1 Polymorphisms on Metformin‐Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance
11. Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography–tandem mass spectrometry and its application to hepatic chemoembolization
12. Site of Alcohol First-Pass Metabolism Among Women
13. Lack of an Effect of Ritonavir Alone and Lopinavir-Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers
14. Influence of Panax ginseng on the Steady State Pharmacokinetic Profile of Lopinavir-Ritonavir in Healthy Volunteers
15. Severe spinal cord injury in craniocervical dislocation. Case-based update
16. The best COVID-19 predictor is recent smell loss: a cross-sectional study
17. Taste and Smell Function in Head and Neck Cancer Survivors
18. Limitations of Using a Single Postdose Midazolam Concentration to Predict CYP3A-Mediated Drug Interactions
19. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
20. Recent smell loss is the best predictor of COVID-19: a preregistered, cross-sectional study
21. Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers
22. A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia
23. Influence of Panax ginseng on Cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) Activity in Healthy Participants
24. Taste and smell function in Wolfram syndrome
25. Echinacea purpurea Significantly Induces Cytochrome P450 3A Activity but Does Not Alter Lopinavir-Ritonavir Exposure in Healthy Subjects
26. Taste and smell function in Wolfram syndrome
27. Lack of In Vivo Correlation Between Indinavir and Saquinavir Exposure and Cytochrome P450 3A Phenotype as Assessed with Oral Midazolam as a Phenotype Probe
28. Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort
29. Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: Results of three studies
30. A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia.
31. Evaluation and management of small dural tears in primary lumbar spinal decompression and discectomy surgery
32. Lack of effect of St Johnʼs Wort on carbamazepine pharmacokinetics in healthy volunteers
33. Indinavir concentrations and St John's wort
34. Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran
35. Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers
36. Effects ofSLC22A1Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance
37. Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort
38. Influence ofPanax ginsengon the Steady State Pharmacokinetic Profile of Lopinavir-Ritonavir in Healthy Volunteers
39. Influence of Low-Dose Ritonavir With and Without Darunavir on the Pharmacokinetics and Pharmacodynamics of Inhaled Beclomethasone
40. Severe spinal cord injury in craniocervical dislocation. Case-based update
41. Influence ofPanax ginsengon Cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) Activity in Healthy Participants
42. Echinacea purpureaSignificantly Induces Cytochrome P450 3A Activity but Does Not Alter Lopinavir-Ritonavir Exposure in Healthy Subjects
43. Gemfibrozil Concentrations Are Significantly Decreased in the Presence of Lopinavir-Ritonavir
44. Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects
45. Influence of Antiretroviral Drugs on the Pharmacokinetics of Prednisolone in HIV-Infected Individuals
46. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects
47. Compartmentalized Intrapulmonary Pharmacokinetics of Amphotericin B and Its Lipid Formulations
48. Ritonavir Decreases the Nonrenal Clearance of Digoxin in Healthy Volunteers with Known MDR1 Genotypes
49. Plasma Pharmacokinetics of Sulfadiazine Administered Twice Daily versus Four Times Daily Are Similar in Human Immunodeficiency Virus-Infected Patients
50. Comparative Drug Disposition, UrinaryPharmacokinetics, and Renal Effects of Multilamellar Liposomal Nystatinand Amphotericin B Deoxycholate inRabbits
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.